Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19Marie Fisk, Joseph Cheriyan, Sven Moosmang et al.|Pulmonary Pharmacology & Therapeutics|2021Cited by 20